Short review. Prospects for cancer immunochemotherapy.
D000818:Animals; D000903:Antibiotics, Antineoplastic / Q000494:pharmacology; D000912:Antibodies, Neoplasm / Q000302:isolation & purification; D000917:Antibody Formation; D000918:Antibody Specificity; D000936:Antigen-Antibody Complex; D000951:Antigens, Neoplasm / Q000302:isolation & purification; D001666:Binding Sites, Antibody; D002286:Carcinoma, Ehrlich Tumor / Q000276:immunology; D002648:Child; D006224:Cricetinae; D004359:Drug Therapy, Combination; D000882:Haplorhini; D006801:Humans; D007110:Immunity, Active; D007112:Immunity, Maternally-Acquired; D007167:Immunotherapy / Q000379:methods*; D007939:Leukemia L1210 / Q000628:therapy; D051379:Mice; D008807:Mice, Inbred BALB C; D009369:Neoplasms / Q000276:immunology / Q000532:radiotherapy / Q000628:therapy*; D009374:Neoplasms, Experimental / Q000628:therapy; D011817:Rabbits
D000903:Antibiotics, Antineoplastic; D000912:Antibodies, Neoplasm; D000936:Antigen-Antibody Complex; D000951:Antigens, Neoplasm